Imaging for Hyperparathyroidism with Renal Involvement
For a patient with hypercalcemia, worsening albuminuria, and rising creatinine, obtain neck ultrasound AND sestamibi SPECT/CT for parathyroid localization, plus renal ultrasound to assess kidney anatomy and exclude obstruction.
Parathyroid Localization Strategy
The clinical picture suggests primary hyperparathyroidism (PHPT) with secondary renal complications. The ACR Appropriateness Criteria 1 establish that imaging has no role in confirming or excluding the diagnosis of hyperparathyroidism—biochemical confirmation must come first. Once biochemically proven, imaging serves solely to localize abnormal parathyroid glands for surgical planning.
First-Line Parathyroid Imaging (Choose Both)
Neck ultrasound is widely recommended as initial imaging, with reported sensitivity of 76-80% and positive predictive value of 93% 1. The ACR guidelines note that both the American Head and Neck Society and American Association of Endocrine Surgeons prefer ultrasound as the initial study, particularly because it simultaneously evaluates the thyroid 1.
Sestamibi scan with SPECT or SPECT/CT should be performed concurrently. The addition of SPECT/CT to planar imaging provides superior anatomic localization 1. When combined with pertechnetate subtraction, sensitivity reaches 93% with 96% positive predictive value 1. The dual-tracer approach (sestamibi plus pertechnetate) with SPECT/CT outperforms dual-phase sestamibi alone 1.
Why Combine Both Modalities
Multiple studies demonstrate that combining examinations improves sensitivity and positive predictive value over either test alone 1. This concordant imaging approach maximizes confidence in parathyroid localization, which is critical for minimally invasive parathyroidectomy—the preferred surgical approach when a single adenoma is confidently localized 1.
Second-Line Imaging (If First-Line Nonlocalizing)
If ultrasound and sestamibi are negative, discordant, or equivocal:
- 4D parathyroid CT (CT neck without and with IV contrast): Sensitivity 79-88%, PPV 84-90% for overall disease; 92-94% sensitivity for single-gland disease 1
- 18F-fluorocholine PET/CT: Emerging as highly accurate, with gland-based sensitivity of 85-89% 2. Recent evidence suggests this may be superior to conventional imaging in difficult cases 3, 4
Important caveat: In your patient with rising creatinine, carefully weigh the risk-benefit ratio of iodinated contrast for 4D-CT. Consider MRI neck or choline PET/CT as alternatives if contrast is contraindicated 5.
Renal Assessment
Renal ultrasound is the appropriate initial imaging for kidney evaluation 6. This modality:
- Assesses renal size and morphology
- Excludes urinary tract obstruction (a reversible cause of renal dysfunction)
- Identifies nephrocalcinosis or nephrolithiasis (complications of hyperparathyroidism)
- Avoids nephrotoxic contrast agents
The ACR Renal Failure guidelines 6 specifically recommend ultrasound as the modality of choice for initial imaging in patients with renal dysfunction, reserving CT and MRI for specific indications like suspected obstruction when ultrasound is inconclusive.
Contrast Considerations
Avoid iodinated contrast in CT studies given the rising creatinine—this could precipitate contrast-induced nephropathy. If 4D-CT becomes necessary for parathyroid localization, the risk-benefit must be carefully evaluated. Gadolinium-based contrast for MRI also requires critical assessment in renal dysfunction 6.
Clinical Context: Primary vs. Secondary Hyperparathyroidism
Your patient's hypercalcemia distinguishes this from secondary hyperparathyroidism (SHPT), which presents with hypocalcemia or normal calcium 1. SHPT occurs in chronic kidney disease as a compensatory response to hypocalcemia. The renal dysfunction here appears to be a consequence of primary hyperparathyroidism rather than the cause, as PHPT commonly causes nephrolithiasis, nephrocalcinosis, and progressive renal impairment 1.
If this were SHPT (multiglandular disease), the imaging approach would differ—all four glands require identification since bilateral neck exploration is necessary 1. However, the hypercalcemia makes PHPT far more likely, where 80-85% have single adenomas 1.
Common Pitfalls
- Don't image before biochemical confirmation: Elevated PTH with hypercalcemia must be documented first
- Don't rely on single modality: Concordant findings on two modalities significantly increase surgical success
- Don't use imaging to diagnose hyperparathyroidism: This is a biochemical diagnosis 1
- Don't forget renal imaging: The rising creatinine and albuminuria require anatomic assessment to exclude obstruction and evaluate for hyperparathyroidism complications